Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
January 20, 2023	SC 13G/A	An amendment to the SC 13G filing	0000093751-23-000018.pdf 0000093751-23-000018.rtf View HTML
January 30, 2023	S-8	Securities offered to employees pursuant to employee benefit plans	0001193125-23-019073.pdf 0001193125-23-019073.rtf 0001193125-23-019073.xls View HTML
February 2, 2023	4	Statement of changes in beneficial ownership of securities	0001562180-23-000832.pdf 0001562180-23-000832.rtf 0001562180-23-000832.xls View HTML
February 2, 2023	4	Statement of changes in beneficial ownership of securities	0001562180-23-000831.pdf 0001562180-23-000831.rtf 0001562180-23-000831.xls View HTML
February 2, 2023	4	Statement of changes in beneficial ownership of securities	0001562180-23-000830.pdf 0001562180-23-000830.rtf 0001562180-23-000830.xls View HTML
February 9, 2023	SC 13G/A	An amendment to the SC 13G filing	0001104659-23-015229.pdf 0001104659-23-015229.rtf View HTML
February 10, 2023	SC 13G/A	An amendment to the SC 13G filing	0000895345-23-000072.pdf 0000895345-23-000072.rtf View HTML
February 17, 2023	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	0001193125-23-042106.pdf 0001193125-23-042106.rtf 0001193125-23-042106.xls View HTML
February 21, 2023	8-K	Report of unscheduled material events or corporate event	0001193125-23-042806.pdf 0001193125-23-042806.rtf 0001193125-23-042806.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
March 1, 2023	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001193125-23-056298.pdf 0001193125-23-056298.rtf 0001193125-23-056298.xls View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax